![]() |
市场调查报告书
商品编码
1784625
2021-2031年亚太地区雷射辅助耳鼻喉手术市场报告(范围、细分、动态和竞争分析)Asia Pacific Laser-Assisted ENT Surgery Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
亚太地区雷射辅助耳鼻喉手术市场规模预计将从 2023 年的 49,406.24 千美元增至 2031 年的 1,17,988.30 千美元。预计 2023 年至 2031 年期间该市场的复合年增长率为 11.5%。
执行摘要和亚太地区雷射辅助耳鼻喉手术市场分析:
雷射辅助耳鼻喉手术在日本获得了显着发展,体现了该国致力于将先进医疗技术融入医疗保健领域的决心。保泽耳鼻喉诊所是专门进行内视镜雷射手术的机构之一,该手术针对喉癌、中耳疾病以及导致声音品质下降的喉部缺陷等疾病。该诊所的院长被誉为日本最优秀的医生之一,他强调雷射技术在提高手术精准度和病人安全方面的重要性。日本的研究和临床研究持续验证雷射辅助耳鼻喉手术的有效性。东京医科大学积极推动雷射技术在耳鼻喉应用领域的研发。该大学与多家医院合作进行临床研究,以验证雷射辅助手术的有效性。这种合作增强了雷射技术的实际应用,并丰富了该领域的整体知识体系。这些研究有助于提供更多证据,支持雷射在各种应用中的应用,从治疗慢性鼻窦炎到对声带进行精细的手术。这些研究报告的积极成果提高了雷射技术的可信度,鼓励更多的从业人员在实践中采用这些技术。
亚太地区雷射辅助耳鼻喉手术市场細項分析:
有助于得出雷射辅助耳鼻喉手术市场分析的关键部分是雷射类型、手术类型和最终用户。
根据雷射类型,雷射辅助耳鼻喉手术市场细分为二氧化碳雷射、Nd.YAG雷射、二极体雷射、蓝光雷射、KTP雷射、氩雷射和其他雷射类型。二氧化碳雷射在2023年占据了最大的市场份额。
就手术类型而言,雷射辅助耳鼻喉手术市场分为雷射喉部手术、雷射内视镜鼻窦手术 (LESS)、雷射辅助悬雍垂腭咽成形术 (LAUP)、雷射辅助镫骨切开术、雷射辅助扁桃体切除术和腺样体切除术、雷射鼻甲缩小手术、经口雷射显微手术 (TLM)、鼻腔手术 (TLM)、鼻内手术类型。 2023 年,雷射辅助扁桃体切除术和腺样体切除术占据了最大的市场份额。
根据最终用户,雷射辅助耳鼻喉手术市场可分为医院和专科诊所、医生办公室和其他最终用户。医院和专科诊所在2023年占据了最大的市场。
亚太地区雷射辅助耳鼻喉手术市场展望
随着医疗技术的进步,医护人员和患者越来越倾向于选择能够最大程度减少创伤、缩短恢復时间并改善疗效的手术方案。这种转变在耳鼻喉科手术中尤其明显,传统的侵入性技术正被精准高效的先进雷射辅助方法所取代。 RAPIDO ENT BLUE 是一款独特的便携式雷射系统,旨在满足各种临床应用的需求,提供接触式和非接触式治疗方案。其便携性和多功能性使其成为希望在无需大量基础设施的情况下扩展手术能力的医护人员的理想之选。
微创手术切口较小甚至无切口,显着降低併发症风险,最大程度减轻术后疼痛,并缩短住院时间。雷射技术的精准性使外科医生能够精准定位特定组织,而不会影响周围区域,这对于涉及咽喉和鼻腔的精细手术至关重要。这种精准度的提升不仅能改善手术效果,还能促进患者更快康復,让患者能更快恢復日常生活。
微创手术需求的不断增长,主要源自于患者对疼痛较小、更有效率治疗方案的偏好。患者对微创手术的了解程度更高,并积极寻求符合其快速康復和最大程度减少生活方式干扰的替代方案。随着人们对雷射辅助技术益处的认识不断提高,预计会有更多患者寻求此类治疗,从而增加雷射辅助耳鼻喉手术的整体需求。医疗保健提供者意识到这一趋势,正在投资先进的雷射技术,以满足患者需求并保持市场竞争力。
因此,微创手术的日益普及正在重塑雷射辅助耳鼻喉手术市场,为成长和创新提供了巨大的机会。随着利害关係人持续投资于这个不断发展的领域,雷射辅助耳鼻喉手术的未来前景光明,有望为全球患者提供更优质的照护和更高品质的生活。
亚太地区雷射辅助耳鼻喉手术市场国家洞察
按国家/地区划分,亚太地区雷射辅助耳鼻喉手术市场包括中国、日本、印度、澳洲、韩国和亚太其他地区。中国在2023年占最大份额。
随着医疗技术的进步以及对微创手术方案的需求不断增长,中国的雷射辅助耳鼻喉手术数量显着增加。这种创新方法利用各种雷射器,例如二氧化碳雷射器和钕钇铝石榴石雷射器,对耳、鼻、喉问题进行精准的手术治疗,从而改善患者的治疗效果并缩短康復时间。根据《耳鼻喉与放射学新闻》报道,与西方国家类似,经口雷射显微手术已在中国各头颈治疗中心广泛应用于治疗早期喉癌。
北京、上海、广州等大城市的医院都已投资先进的雷射技术,使外科医生能够更精准地执行复杂的手术,并减少对周围组织的伤害。这种精准度在喉部和鼻腔等敏感部位尤其有效,而传统的手术方法在这些部位併发症风险更高。 2023年12月,復旦大学附属眼耳鼻喉科医院浦江院区二期工程在闵行区农村地区开工建设,计划在现有350张床位的基础上再增加150张床位。中国政府鼓励将先进技术融入医疗实践,从而推广雷射辅助手术的应用。政府也支持实施外科医生培训项目,使他们能够掌握有效运用雷射技术的必要技能。因此,许多耳鼻喉专科医生都精通雷射技术。
亚太地区雷射辅助耳鼻喉手术市场公司概况
市场上的一些主要参与者包括 biolitec AG (Biolitec)、Iridex Corporation、Medency、Dimed Laser Technology Co., Ltd.、intros Medical Laser GmbH、ARC Laser GmbH、LightScalpel、GIGAAMEDICAL、INTERmedic ARFRAN、Limmer Laser GmbH、Qolight这些参与者正在采用扩张、产品创新和併购等各种策略,为消费者提供创新产品并增加市场份额。
亚太地区雷射辅助耳鼻喉手术市场研究方法:
本报告中的资料收集和分析遵循了以下方法:
二手资料研究:研究流程始于全面的二手资料研究,利用内部和外部资源收集每个市场的定性和定量资料。常用的二手资料研究来源包括但不限于:
公司网站、年度报告、财务报表、经纪商分析和投资者介绍。行业期刊及其他相关出版品。政府文件、统计资料库和市场报告。针对在市场运营的公司的新闻文章、新闻稿和网路广播。註:公司简介部分所包含的所有财务资料均已标准化为美元。对于以其他货币报告的公司,数据已使用相应年份的相关汇率转换为美元。
一手研究 Insight Partners 每年都会与行业利益相关者和专家进行大量的一手调查,以验证其资料分析,并获得宝贵的见解。这些研究访谈旨在:
验证并完善二手资料研究的结果。提升分析团队的专业知识和市场理解。深入了解市场规模、趋势、成长模式、竞争动态和未来前景。一手资料研究透过电子邮件互动和电话访谈进行,涵盖不同地区的各种市场、类别、细分市场和次细分市场。参与者通常包括:
产业利害关係人:副总裁、业务发展经理、市场情报经理和国家销售经理外部专家:估值专家、研究分析师和具有行业专业知识的关键意见领袖
The Asia Pacific Laser-Assisted ENT Surgery Market size is expected to reach US$ 1,17,988.30 thousand by 2031 from US$ 49,406.24 thousand in 2023. The market is estimated to record a CAGR of 11.5% from 2023 to 2031.
Executive Summary and Asia Pacific Laser-Assisted ENT Surgery Market Analysis:
Laser-assisted ENT surgeries have gained significant traction in Japan, reflecting the country's commitment to integrating advanced medical technologies into healthcare. Hozawa ENT Clinic is one of the facilities specializing in endoscopic laser surgeries for conditions such as laryngeal cancer, middle ear disorders, and laryngeal defects leading to voice quality degradation. The clinic's director, recognized as one of Japan's best doctors, emphasizes the importance of laser techniques in improving surgical precision and patient safety. Research and clinical studies in Japan continue to validate the effectiveness of laser-assisted ENT surgeries. Tokyo Medical University has proactively promoted research and development in laser technologies for ENT applications. The university collaborates with various hospitals to conduct clinical studies validating laser-assisted procedures' effectiveness. This collaboration enhances the practical application of laser technology and contributes to the overall body of knowledge in the field. Such studies contribute to an expanding pool of evidence supporting the use of lasers in various applications, from treating chronic sinusitis to performing delicate surgeries on the vocal cords. The positive outcomes reported in these studies enhance the credibility of laser techniques, encouraging more practitioners to adopt them in their practices.
Asia Pacific Laser-Assisted ENT Surgery Market Segmentation Analysis:
Key segments that contributed to the derivation of the laser-assisted ENT surgery market analysis are laser type, surgery type, and end user.
By laser type, the laser-assisted ENT surgery market is segmented into CO2laser, Nd.YAGlaser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO2laser held the largest share of the market in 2023.
In terms of surgery type, the laser-assisted ENT surgery market is divided into laser laryngeal surgery, laser endoscopic sinus surgery (LESS), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinate reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held the largest share of the market in 2023.
Based on end user, the laser-assisted ENT surgery market is categorized into hospitals and specialty clinics, physician office, and other end-users. The hospitals and specialty clinics segment held the largest share of the market in 2023.
Asia Pacific Laser-Assisted ENT Surgery Market Outlook
As medical technology advances, healthcare providers and patients increasingly lean toward surgical options that minimize trauma, reduce recovery time, and enhance patient outcome. This shift is particularly evident in ENT surgery, where traditional invasive techniques are being replaced by state-of-the-art laser-assisted methods that offer precision and efficiency. RAPIDO ENT BLUE is a unique portable laser system designed to meet various clinical applications' demands, offering contact and non-contact treatment options. Its portability and versatility make it an attractive choice for healthcare providers looking to expand their surgical capabilities without requiring extensive infrastructure.
Minimally invasive procedures utilize smaller or no incisions, significantly decreasing the risk of complications, minimizing postoperative pain, and shortening hospital stays. The precision of laser technology allows surgeons to target specific tissues without affecting surrounding areas, which is crucial in delicate procedures involving the throat and nasal passages. This enhanced accuracy improves surgical outcomes and fosters quicker recoveries, enabling patients to return to their daily activities sooner.
The rising demand for minimally invasive procedures is primarily driven by patient preferences for less painful and more efficient treatment options. Patients are more informed and actively seek alternatives that align with their desire for quick recovery and minimal lifestyle disruption. As awareness of the benefits of laser-assisted techniques spreads, more patients are expected to request these options, increasing the overall demand for laser-assisted ENT surgeries. Healthcare providers, recognizing this trend, are investing in advanced laser technologies to meet patient needs and remain competitive within the market.
As a result, the increasing adoption of minimally invasive procedures is reshaping the laser-assisted ENT surgery market, providing numerous opportunities for growth and innovation. As stakeholders continue to invest in this evolving landscape, the future of laser-assisted ENT surgery looks promising, with the potential to deliver enhanced care and improved quality of life for patients worldwide.
Asia Pacific Laser-Assisted ENT Surgery Market Country Insights
Based on country, the Asia Pacific laser-assisted ENT surgery market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2023.
The number of laser-assisted ENT surgeries has increased significantly in China due to advancements in medical technology and an increasing demand for minimally invasive surgical options. This innovative approach utilizes various lasers, such as CO2 and neodymium YAG lasers, to perform precise surgical procedures for the treatment of ear, nose, and throat issues, enhancing patient outcomes and reducing recovery times. According to ENT and Radiology News, similar to Western countries, transoral laser microsurgeries for early laryngeal cancer has been adopted widely at different head and neck treatment centers in China.
Hospitals across major cities such as Beijing, Shanghai, and Guangzhou have invested in state-of-the-art laser technology, allowing surgeons to perform complex procedures with greater accuracy and less trauma to surrounding tissues. This precision is particularly beneficial in delicate areas such as the larynx and nasal passages, where traditional surgical methods may pose higher risks of complications. In December 2023, construction started on the second phase of the Pujiang branch of Fudan University's eye, ear, nose, and throat hospital in the rural region of Minhang District; the plan involves the addition of another 150 beds to the existing capacity of 350. The Chinese government promotes the adoption of laser-assisted surgeries by encouraging the integration of advanced technologies in medical practice. It also provides support for the implementation of training programs for surgeons, enabling them to acquire the necessary skills to utilize laser technology effectively. As a result, many ENT specialists are proficient in laser techniques.
Asia Pacific Laser-Assisted ENT Surgery Market Company Profiles
Some of the key players operating in the market include biolitec AG (Biolitec); Iridex Corporation; Medency; Dimed Laser Technology Co., Ltd.; intros Medical Laser GmbH; ARC Laser GmbH; LightScalpel; GIGAAMEDICAL; INTERmedic ARFRAN; Limmer Laser GmbH; Qolight Medical Laser; and Sisram Medical Ltd., among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Asia Pacific Laser-Assisted ENT Surgery Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise